Raymond Despax

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

Medicine, Oncology, Pharmacology +17

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP).

G Mathé, Yoshinori Kidani, K Triana et al. · PubMed · 1986 · 92 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros et al. · Clinical Cancer Research · 2023 · 26 citations · Full text

Medicine, Gynecology, Oncology +17